Stroke

Latest Features

Reducing Neurologic Damage After Stroke With Ischemic Preconditioning

Reducing Neurologic Damage After Stroke With Ischemic Preconditioning

Ischemic preconditioning may provide neuroprotective effects that reduce stroke infarct size and improve recovery times.

Examining Cardiovascular Disease Risk Associated With Hepatitis C Infection

Examining Cardiovascular Disease Risk Associated With Hepatitis C Infection

Hepatitis C virus infection is a common cause of chronic liver disease worldwide and is associated with greater mortality.

Improving Stroke Diagnosis Accuracy: An Expert Interview

Improving Stroke Diagnosis Accuracy: An Expert Interview

An interview with David E. Newman-Toker, MD, PhD, on reducing the frequency of misdiagnoses.

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

A declining trend in ischemic events was associated with oral anticoagulant therapy after intracranial hemorrhage.

Transient Ischemic Attack Treatment Strategy Changes May Have Led to Lower CV Events Risk

Transient Ischemic Attack Treatment Strategy Changes May Have Led to Lower CV Events Risk

Risk for stroke and other vascular events at 90 days was 3.7% vs 12% to 20% in previous cohorts.

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Occlusion of the left atrial appendage provides protection against thromboembolic stroke in patients with nonvalvular atrial fibrillation.

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Choosing the right anticoagulant agent can be a challenge for many reasons, including cost, familiarity, drug interactions, and reversibility.

Stroke Prevalence and Risk May Be Higher in Patients With Asymptomatic Atrial Fibrillation

Stroke Prevalence and Risk May Be Higher in Patients With Asymptomatic Atrial Fibrillation

Risk and prevalence of stroke in patients with undiagnosed asymptomatic atrial fibrillation remains problematic for patients and clinicians.

Guidelines for Management of Hypertension With Stroke Remain Unclear

Guidelines for Management of Hypertension With Stroke Remain Unclear

Guidelines for hypertension management during acute stroke are based on clinician experience.

Latest News

Stroke Outcomes With and Without HIV Compared

Stroke Outcomes With and Without HIV Compared

Patients with HIV have similar stroke outcomes and comorbid conditions compared with older patients who are HIV negative.

Stent Retriever vs Contact Aspiration for Ischemic Stroke Treatment

Stent Retriever vs Contact Aspiration for Ischemic Stroke Treatment

A first-line contact aspiration technique demonstrates no significant benefit over the stent retriever technique in achieving revascularization in patients with acute ischemic stroke.

Post-Stroke Atrial Fibrillation Increases Risk for Cognitive Deficits

Post-Stroke Atrial Fibrillation Increases Risk for Cognitive Deficits

Risk for poststroke cognitive impairment is increased by the presence of atrial fibrillation.

New Atrial Fibrillation After Stroke Tied to Preexisting Cardiovascular Comorbidities

New Atrial Fibrillation After Stroke Tied to Preexisting Cardiovascular Comorbidities

Patients diagnosed with new atrial fibrillation after ischemic stroke were more likely to have preexisting cardiovascular comorbidities such as hypertension, heart failure, and coronary artery disease.

Long-Term Aspirin Unnecessary Following Atrial Fibrillation Ablation

Long-Term Aspirin Unnecessary Following Atrial Fibrillation Ablation

Patients with atrial fibrillation who are at a low risk for stroke do not receive a major benefit from long-term aspirin therapy.

New S2TOP-BLEED Score Estimates Bleeding Risk in Ischemic Stroke

New S2TOP-BLEED Score Estimates Bleeding Risk in Ischemic Stroke

The S2TOP-BLEED score which estimates the 3-year risk of major bleeding in patients with a history of ischemic stroke or transient ischemic attack treated with antiplatelet agents.

Risk Factors for Major Bleeding After Stroke With Antiplatelet Therapy

Risk Factors for Major Bleeding After Stroke With Antiplatelet Therapy

A 3-year major bleeding risk can be determined by using the S2TOP-BLEED score in patients with ischemic stroke using antiplatelet agents.

Greater CV Benefit With Rivaroxaban Plus Aspirin vs Monotherapy in Stable ASCVD

Greater CV Benefit With Rivaroxaban Plus Aspirin vs Monotherapy in Stable ASCVD

Despite more major bleeding events, rivaroxaban plus aspirin therapy had a greater cardiovascular benefit in patients with stable atherosclerotic vascular disease vs monotherapy.

Fixed Dose COPD Treatments Have Similar CV Risks as LABAs/ICS

Fixed Dose COPD Treatments Have Similar CV Risks as LABAs/ICS

The combination of long-acting β2-agonist (LABA)/ and long-acting muscarinic antagonist (LAMA) is linked to a similar or lower risk of cardiovascular and cerebrovascular adverse events compared to treatment with LABA/inhaled corticosteroid.

FDA Issues Safety Alert for Revascularization Device Used in Acute Ischemic Stroke

FDA Issues Safety Alert for Revascularization Device Used in Acute Ischemic Stroke

The delivery wire component of the Penumbra 3D revascularization device may break or separate during use.

Sign Up for Free e-Newsletters